Drawing for BIFIVIR

USPTO serial 79016161

BIFIVIR

Reviewed by CopyMark Law Group

Reg. 3165463Status 404
Filing date
Status date
Registration date
Oct 31, 2006
Examiner
MARTIN, JENNIFER MCGARRY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIFIVIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Concentrated bacterial cultures having probiotic action in human and farm animal organisms, for medical or veterinary use, to be used in the production of vaccines for human use and vaccines for veterinary use in particular for anti-flu vaccines, or antiviral vaccines for the preventive treatment of flu; microorganism cultures, in particular lactic bacteria having probiotic action in human and farm animal organisms, for medical or veterinary use in the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, for use in preventing intestinal inflammation in which inflammation is present on the intestinal wall, and for use in the treatment and prevention of antibiotic associated diarrhea; pharmaceutical products for treating or eliminating bacteria, fungi and viruses on the skin and in the mucous membranes; enteric compositions, comprising cultures of microorganisms having probiotic action for medical and veterinary use to treat intestinal diseases; pharmaceutical products comprising bacteria cultures for the preparation of vaccines for veterinary use in particular for anti-flu vaccines or antiviral vaccines for the preventive treatment of fluSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Aug 21, 2015DETHDEATH OF INTERNATIONAL REGISTRATION
Feb 26, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 27, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 2, 2014XXSSGENERIC MADRID TRANSACTION SENT TO IB
Nov 1, 2014XXCRGENERIC MADRID TRANSACTION CREATED
May 27, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 27, 2013C71TCANCELLED SECTION 71
Oct 2, 2008NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 25, 2008NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 10, 2008CHLDCHANGE OF OWNER RECEIVED FROM IB
Mar 8, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 6, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 6, 2007FIMPFINAL DISPOSITION PROCESSED
May 29, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 31, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 15, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2006NPUBNOTICE OF PUBLICATION
Jun 21, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 9, 2006ALIEASSIGNED TO LIE
Jun 5, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2005RFNTREFUSAL PROCESSED BY IB
Nov 16, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 9, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2005DOCKASSIGNED TO EXAMINER
Nov 7, 2005NWAPNEW APPLICATION ENTERED
Nov 3, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance